Good morning, and welcome to GoHealth's First Quarter 2025 Earnings Conference Call. My name is Tanya, and I will be your operator for today's call. Currently, all participants are in a listen-only mode. Following the prepared remarks, we will conduct a question-and-answer session. As a reminder, this conference is being recorded. I will now turn the call over to John Shave, Vice President of Investor Relations. John, you may begin.

Thank you, and good morning. Welcome to GoHealth's first quarter 2025 results call. Joining me today are Vijay Kotte, Chief Executive Officer; and Brendan Shanahan, Chief Financial Officer. Today's conference call contains forward-looking statements based on our current expectations. Numerous known and unknown risks and uncertainties may cause actual results to differ materially from those anticipated or projected in these statements. Many of the factors that will determine future results are beyond the company's ability to control or predict. You should not place undue reliance on any forward-looking statements, and the company undertakes no obligation to update or revise any of these statements, whether due to new information, future events, or otherwise. Earlier today, we issued a press release containing our results for the first quarter 2025. We have posted the release on the GoHealth website under the Investor Relations tab. In the press release, we have listed certain risk factors that you should consider in conjunction with our forward-looking statements. We encourage you to consider the other risk factors described in our Form 10-K and Form 10-Q reports filed with the SEC for additional information. During this call, we will be discussing certain non-GAAP financial measures. These measures are reconciled to the most directly comparable GAAP financial measure in our press release. You may also refer to the investor relations presentation posted to the Investor Relations section of our website for reconciliations of non-GAAP measures to the most comparable GAAP measures discussed during this earnings call. I will now turn the call over to GoHealth's CEO, Vijay Kotte.

Thank you, John, and thank you all for joining us today. Our performance during Q1's open enrollment exceeded our expectations for submissions, revenue, and adjusted EBITDA. For those new to the GoHealth story, our mission is to provide support, clarity, and peace of mind to Medicare consumers in a landscape often marked by confusion and uncertainty. The U.S. has over 67 million Medicare-eligible consumers with over half enrolled in Medicare Advantage, or MA. In many geographic regions, consumers face over 40 different plan options, creating confusion and deterring them from exploring better options. GoHealth seeks to simplify these decisions by empowering consumers with unbiased tools and guidance. At GoHealth, we strive to empower Medicare-eligible consumers with proprietary and unbiased tools used by our highly trained and experienced licensed agents. We have evolved from a traditional Medicare enrollment company to a Medicare engagement company, focusing on building long-term, high-quality relationships with our consumers. We believe this shift allows us to deliver a more integrated and personalized approach to care, reinforcing our unique role in the Medicare landscape. With that said, let me now turn to our first quarter results, which highlight strong operational execution and meaningful progress across our financial and strategic priorities. Our performance in the quarter exceeded our expectations. Notably, submission volume in Q1 increased from the previous year, driven by our captive Medicare team's impressive 64% year-over-year growth, while agent headcount only grew by 24% year-over-year. Our Q1 2025 revenue increased to $221 million compared to $186 million in Q1 2024, representing a 19% improvement. Q1 2025 adjusted EBITDA grew to $42 million, a 56% year-over-year improvement. Our Q1 results were driven by another quarter of improvements within our agent productivity. Thanks to the combination of stronger training programs and broader adoption of our AI-driven tools, including PlanGPT and the PlanFit tool, we cut enrollment average handle times by 12% compared to the same period last year. More importantly, our captive agents served more consumers per day, while still improving conversion rates. This balance between speed and quality shows the strength of our model and the discipline we've built into our operation. Similar to what we communicated after AEP, we attempt to deploy our capital to drive the most appropriate balance of risk and return. We have invested in valuable year-over-year growth, driven by our strong direct cost of submission, or CAC, conversion rates, and capacity expansion. Due to a higher mix of agency versus non-agency submissions, we reported a year-over-year decrease in cash flow from operations of $25 million. And in line with our product mix expectations, a 15% year-over-year decrease in sales per submission. Reflecting on our first quarter performance, I want to take a few minutes to highlight three exciting developments that enable us to expand our ability to serve consumers. First is the launch of a new suite of products in the life insurance space, which we have called GoHealth Protect. Second is the continued evolution of our PlanFit platform. And third, there are several new technology enhancements that are already making a meaningful impact. As we continue to focus on innovation and diversification, we're excited to share that GoHealth has launched GoHealth Protect, a suite of products to cover unexpected life events, with the expansion into guaranteed acceptance life insurance, often referred to as Final Expense Insurance, as the inaugural product. Guaranteed acceptance life insurance is a simple, affordable product designed to help families cover the cost of funeral and burial expenses. This move is a natural extension of our core business and GoHealth's mission to ensure consumers' peace of mind when making healthcare decisions, enabling them to focus on living lives. Our Medicare Advantage platform has been the foundation of GoHealth's success. But it's also inherently seasonal, with most of our activity concentrated around the annual enrollment period, or AEP. That seasonality limits our ability to drive consistent revenue and cash flow throughout the year. GoHealth Protect, led by our initial guaranteed acceptance life insurance offering, begins to help us solve that problem. This product offering aligns perfectly with our commitment to bringing peace of mind to the consumers we serve. We expect that it will also allow us to better support our existing customer base. We see a real opportunity here. Roughly half of the population over 65 does not have any life insurance coverage today. We also generate millions of leads annually across the same population. By leveraging our pre-existing relationship with this consumer base and our existing sales infrastructure, we believe we will be able to drive growth in a cost-effective way without significant new investment. I'm encouraged by the early progress. During the first quarter, we launched a partnership with a leader in the guaranteed acceptance life insurance space. Their strong brand and simplified product offering have made them a great fit for our go-to-market approach. Together, we aim to deliver a high-quality, consumer-friendly product that our agents are genuinely excited to sell. With a significant percentage of our agents already holding life insurance licenses, the response has been overwhelmingly positive. And we expect this strong momentum to continue in the second quarter. From a financial standpoint, the economics are consistent with the structure and return profile of our non-agency contracts. The economic value for policy is attractive when factoring in average duration, expected persistency, and a materially lower acquisition cost compared to our core Medicare business. This creates strong unit economics and accelerated cash realization. In short, our move into GoHealth Protect is a highly strategic step for GoHealth. It diversifies our product portfolio, minimizes revenue seasonality, and we anticipate it will put us on a clear path toward long-term profitable growth. We believe it aligns with our mission, empowers our agents, and most importantly, allows us to better serve the consumers who count on us. As GoHealth Protect was in its early testing phases during Q1, there was minimal contribution to revenue and adjusted EBITDA. However, we expect it to continue to ramp in Q2 and Q3, and thus, be a meaningful contributor to the full-year 2025 results and beyond. Second, we believe our Encompass and PlanFit platforms continue to set us apart and gain traction. These tools give consumers tailored guidance, whether that's enrolling in a new plan, finding a better fit, or simply validating that their current plan is still the best choice. In Q1, PlanFit checkups grew 27% year-over-year, a strong sign that consumers are engaging more actively with us. Given the disruptions caused by plan exits and benefit changes, we saw a higher rate of plan switches than usual. At the same time, we helped roughly 15,000 consumers stay in their existing plans, reinforcing our focus on long-term value, not just short-term sales. Early results are encouraging, and we expect the program to keep growing. Third, we delivered several important technology launches with a concentration on automation and artificial intelligence that are enhancing both the consumer experience and agent efficiency. In early April, we launched MyGoHealth, giving consumers the ability to create a profile, save their personal information, and manage their Medicare journey more easily. We also piloted a unified enrollment experience that consolidates carrier applications into a single streamlined process. Agents have already reported seeing faster enrollment and a simpler workflow. For our GPS downline agencies, we completed the move to GPS Express, an innovation to our enrollment system that has improved the efficiency of the post-sale consumer experience. On the GoHealth Protect expansion, we rolled out inbound marketing leads to our agents. And as expected, conversion rates are higher with manual outbound dialing. And finally, our marketing and operations teams have deployed a differentiated approach towards identifying, tailoring messaging, and conducting a deep needs assessment with consumers who may qualify for chronic condition special needs Medicare plans, or C-SNPs. Taken together, we believe these operational and technological investments are already driving better engagement, greater efficiency, and a stronger platform for sustainable growth. Additionally, we'd like to highlight a key regulatory development. CMS announced a 5.06% average increase in Medicare Advantage revenue for health plans, along with a 10.72% increase to the Broker Commission Schedule in its final rate notice. This represents the most significant adjustment in over a decade and underscores the continued strength of the Medicare Advantage program. It also affirms the important role brokers play in helping beneficiaries navigate their options. Looking ahead to the 2025 AEP, while we continue to anticipate positive market dynamics, our outlook has evolved. We anticipate another disruptive AEP. Some early indication of the upcoming disruption are the decisions made by health plans, both during the fourth quarter of 2024 and more recently, in Q2 to suppress plan commission eligibility, to be even more targeted on where they want to grow, hold, or pull back for the remainder of plan year 2025. We believe these moves indicate a likely repricing of plan benefits to right-size margin profiles that will likely result in more consumers needing to assess their options. Due to our expectation to see health plans de-emphasize growth in Q2 and Q3, also referred to as the special election period, or SEP, as well as the continued evolution of the Medicaid dual eligible changes, we plan to continue to shift more capacity into GoHealth Protect for the remainder of SEP as we prepare for another dynamic shopping season in the fourth quarter. We will continue to monitor the market behavior, and ultimately, wait to see what happens with final health plan bids and product benefit changes to get a better view on the shopping and appropriate switching behaviors we can expect to see with consumers going into the 2026 plan year. We believe the market condition will be favorable ahead, though our ability to capitalize on those conditions will be dependent on the health plan's benefit decisions, appetite for growth, and willingness to invest in the high-value service GoHealth provides, alongside our operational and capital efficiency. Before I turn the call over to Brendan for a more detailed review of our financial results, I want to briefly address a matter that, while not new, has recently taken a procedural step forward. GoHealth is aware that the United States Attorney's Office has decided to intervene in a qui tam lawsuit that names multiple defendants, including GoHealth. The claims in both the action by the government as well as the original complaint are based on alleged violations of the False Claims Act and the Anti-Kickback Statute. This case has been under seal and inactive for several years since it was originally filed. GoHealth firmly denies the allegations made by the government in this lawsuit related to events that allegedly occurred between 2016 and 2021. We are disappointed that the government is pursuing claims against the company that strives to advance the interests of the Medicare Advantage Program and the Medicare beneficiaries it serves. We intend to vigorously defend against these claims and will not allow this litigation to distract us from our mission to provide peace of mind to the Medicare beneficiaries we serve. While we take this matter seriously, it does not change our focus or our momentum. We do not intend to further comment on ongoing litigation. Now, I will turn the call over to Brendan Shanahan, our CFO, who will provide a more detailed review of our financial performance for Q1.

Thank you, Vijay. I will continue with the review of our financial performance for the first quarter of 2025. First quarter revenue totaled $221 million, representing a 19% increase compared to Q1 2024. Higher captive agency submission volumes drove growth, helped by improved operational efficiency. While we reported a GAAP net loss of $9.8 million this quarter, this reflects a significant improvement year-over-year and is progress toward our goal to drive long-term profitability. Importantly, our adjusted EBITDA for Q1 2025 totaled $42.1 million, a 56% increase from $26.9 million in Q1 2024, which we believe demonstrates the underlying strength and scalability of our model. Cost optimization efforts across marketing, agent training, and operational infrastructure significantly improved our margins. A key driver of these results was the Q1 reduction in our direct operating costs per submission or customer acquisition costs by 18%, from $640 to $522, which we believe is a testament to our targeted marketing strategies and efficient agent performance. On the cash flow front, we reported negative cash flow from operations of $12.4 million compared to a positive $12.5 million in the prior year period, primarily driven by the mixed shift from non-agency to agency. Likewise, our commissions receivable grew to over $1 billion at quarter end, growing nearly 19% year-over-year due to the same mixed shift from non-agency to agency, reinforcing the durability and scale of our business. Discipline guides our decision-making as we constantly evaluate how much growth to pursue, recognizing that these are conscientious choices. Every quarter, we weigh how much we want to invest to pursue additional growth versus how much we're willing to leave on the table to preserve margin or cash flow. And we do so with flexibility and financial discipline to adapt to evolving market dynamics. A great example of this is our GoHealth Protect initiative, which was deployed and launched during the first quarter. It's still early, but we are excited about the potential. This business shares similar cash dynamics with our non-agency model, where fees are paid more quickly, which will help reduce seasonality in our cash flow and drive a more predictable revenue and margin profile. As GoHealth Protect scales, we expect it will contribute to lowering our customer acquisition costs, especially as agents are able to serve more consumers with multiple product options. That's a powerful economic advantage and one we believe we are well-positioned to capture, in part because we've secured proprietary contracts that are differentiated across the industry. These agreements give us unique access and flexibility to serve consumers in ways that few others can replicate. Looking more broadly, we remain highly focused on capital discipline and maximizing return on investment. We continue to actively evaluate how to best deploy our resources, whether through growth investments, technology acceleration, or further capital structure optimization. Our goal is to reduce our cost of capital and reinvest in the business in ways that drive long-term value. We will be thoughtful and selective. We will continue to monitor the market and pursue only those alternatives that offer attractive economics and strategic alignment. With continued favorable market dynamics and a potentially disruptive AEP, we expect further progress in margin expansion, operating efficiency, and returns on our technology investments. We believe the market will continue to reward models that combine personalized service with operational excellence and the ability to adapt in real time. I will now hand it back to Vijay for his closing remarks.

Thank you, Brendan. Our first quarter results underscore the strength of our model and disciplined execution, along with continued momentum in helping seniors navigate Medicare with greater clarity. We believe our innovation and deployment of AI tools are empowering our agents and leading to better consumer experiences, improving plan fit, building trust, and strengthening long-term relationships. Early traction from GoHealth Protect is equally encouraging, extending our value to existing consumers, opening the door to new consumers, reducing seasonality, and enhancing unit economics through multi-product engagement. As we move forward, we remain focused on leveraging our platform, agent network, and consumer trust to thoughtfully expand into adjacent verticals aligned with our mission. Thank you for your time and interest. Operator, we're now ready for questions.

Thank you. One moment for our first question, which will come from Rob McGuire of Granite Research. Your line is open.

Good morning, and thank you for taking my call.

Good morning, Rob.

Yes. Good morning. Terrific. So, regarding your capital structure, can you just provide an idea of whether there are opportunities to improve your capital structure at this point, or do you think that the DOJ's actions might defer that for the time being?

Look, I think we have always commented that there are going to be multiple scenarios and multiple alternatives in how we think about our capital structure. We have a term loan. We have revolvers. We have a lot of different alternatives as to how we can think about running and investing in the business. We are always assessing becoming more efficient to open up more doors to do more things. And I think some of the innovation around new products like GoHealth Protect will support the way we want to invest in the business and finding different ways to do that internally. As Brendan said in his prepared comments, we will make sure that whatever we do consider is the right time and the right terms, that will improve our position, not make it weaker. So, we're going to continue to assess it under those considerations. But more importantly, what I would tell you is that the DOJ piece by itself is something that we're going to be working on separately as we just described, but it doesn't change our plans to go ahead and assess multiple alternatives and all the different options out there to enhance our capital structure so that we can invest in the business appropriately.

Thanks, Vijay. And then, this morning, I don't know if you caught the news on United, but I was just curious. You made comments regarding the fourth quarter AEP. Do you have any thoughts on United and the changes that they're experiencing? Can you provide more detail on your expectations for this year's coming AEP versus last year on a relative basis?

Yes. No, I did see the news. It's a little early to digest all of that. But what I would say is that across the industry, there has been no deficit of health plans describing some of their margin challenges either last year or coming into this year and/or in their attempts to try to manage their margins and/or their growth profile as they move into the new plan year of 2026, so this transitionary period. As I indicated earlier, we're reading those tea leaves as best as we can. And what that tells us is that the health plans are uncertain about the margin profiles or having challenges with those margins even into '25, as they either have announced that in their earnings or they have pulled back on what they're making commission eligible in their sales. And that is a strong indication that those are products that need to be reset because they don't meet the margin threshold or they are seeing unexpected margin and medical expense trends or otherwise. What we see that to mean is that there's a higher likelihood that there are going to be more benefit resets and disruptions coming in the upcoming AEP, especially in those products that didn't get reset last year. If you wrote products that were redesigned already for last year, those are probably good products. For the products that didn't get reset or where market competitiveness wasn't able to be assessed at the time when health plans introduced 2025 benefit plans back last October, those are the ones most likely to be reset. So, we don't know for sure. We're going to have to monitor for the rest of the year. But early indications lead us to believe there are going to be more benefit adjustments going into the next AEP. This is likely to cause a new shopping experience or demand for shopping and comparison of options for consumers.

Thank you. And our next question will come from Pat McCann of Noble Capital Markets. Pat, your line is open.

Hey, thanks. Good morning. Thanks for taking my questions. First of all, I wanted to ask about GoHealth Protect. Are you partnering with a specific carrier or carriers? What are the mechanics of that offering? And how does that impact the marketing strategy? Is this something where you are marketing specifically for that offering or is it added on as an additional sales point after a consumer comes through the top of the funnel that you already have implemented for the Medicare Advantage business?

Good morning, Pat. Thanks for the question. What I would say is this. It's first and foremost, this guaranteed acceptance life insurance, or final expense insurance, is not a novel concept. People do it. What GoHealth is doing here is similar to the way we think about how we deliver on Medicare Advantage. We don't have to be the first mover, but we will do it with a consumer-oriented lens and we'll do it more efficiently through our standardization, technology, and innovative approach to marketing to match consumers with the products that they need. In this vein, as we've been testing it in Q1 going into Q2, we want to be thoughtful about how many partners we bring into that. So, we've been selective in that process. We've been testing all different approaches between doing outbound and serving consumers who are already with us and who have demonstrated some interest versus also doing some inbound marketing to find consumers who would respond to the marketing on a more direct response basis for this type of product. So, we've been testing all of it as we do with Medicare Advantage, and we have a balanced approach to how we do that. Over time, we will see the different products and different alternatives available for consumers and ensure that, within a portfolio of what we expect to be expanding with GoHealth Protect, more products are offered to match those needs. Those may be with the same carrier or multiple carriers. It really depends on what we assess as the consumer demand. I'm pretty excited about it because we have proven that once we find an economic structure and value proposition that matches with the consumers we serve and the operating model we deliver, we can scale it and really lead within the industry. We expect to be scaling to be just that in this product portfolio. More to come. It is still early. We don't want to go too broad, too fast because that makes it hard to excel. We will proceed slowly, steadily, and calculatedly, but as we indicated, we will continue to ramp through Q2 and Q3 and expect it to be meaningful as we move forward.

Thanks, that's helpful. And then, my last question was just I wanted to touch on something in the presentation, the sales per submission being down 15%. You mentioned that was within expectations. Can you quickly touch on that and what was going on behind the scenes there?

Yes. So, it's a great question, Pat, and I think there's a reason why I wanted to explicitly call it out in our prepared remarks, which is because we saw the same dynamic. We saw actually 16% drop in the fourth quarter year-over-year, and now it's 15.4% this quarter year-over-year. That is the exact same dynamic happening, which is agency versus non-agency. It's a mixed shift between the non-agency contracts and agency contracts. As you may recall, back when we originally went into the non-agency business in late 2022, we were actively choosing which products and health plans to shift over. When we made that shift, we got a pickup in sales per submission for those non-agency contracts. As the mix dynamic shifts back to agency, which is the best product that matches the consumer's needs, we don't influence that balance. Then you're going to see the opposite effect where the blended average comes down. The isolated rates for agency and non-agency aren't necessarily changing; it's the mix shift driving that change in perception of sales per submission. That's why, in line with the change in mix shift from non-agency to agency that we saw in Q4, you'll see that continue to run in Q1. That's why it's the same story and underlying costs.

Okay. And our next question will be coming from James Sidoti of Sidoti & Company. James, your line is open.

Hi, good morning. Thanks for taking the questions. You had some impressive growth regarding the number of submissions. Can you break it out? Can you tell us how many of those submissions came from the recently acquired e-TeleQuote agents?

Yes. As we think about our operating model coming out of the fourth quarter and the first quarter of this year, we've actively started to integrate as much as possible. We've shifted some of the agents to get better distribution, oversight, and more consistency with our historically GoHealth captive team now integrated with ETQ. We're getting much more integrated in that. So, we're not going to split out the agent count because now it's more mixed within all of our teams rather than a distinct one. There is a smaller agent base still managed predominantly by CT or ETQ leadership. But I'd say, year-over-year, we got a 25% agent headcount increase available on the floor in Q1, and a good portion of that came from ETQ as part of that transaction late last year.

Okay, all right. And then, when we look at the last two quarters, despite the lower revenue per submission, you were able to grow total revenue 40% in the fourth quarter and 20% this quarter. I know you don't provide specific guidance, but do you think those trends will continue in June and September? Do you think you'll have higher revenue relative to a year ago?

That's again, as I've indicated, we're thinking about how we're going to look at the full year. We're reading and reacting to how the health plans behave in Q2 and Q3. You want to be nimble there, to assess the most efficient use of capital and what would be the greatest avenue for investment to allow you capacity to react to whatever the fourth quarter looks like. So, I know it sounds inconclusive. We are optimistic about what the shopping dynamic will look like in the fourth quarter. In Q2 and Q3, we're seeing it's not the greatest environment as health plans are pulling back, and you have to be thoughtful about where to grow relative to that and their interest in growing. That is why we're introducing GoHealth Protect, to hedge against that, so we have more stability and predictability in Q2 and Q3, irrespective of what health plans in the MA space are doing. Long story short, I'm not prepared to provide clear indications regarding revenue year-over-year. What I can say is that we are making observations. We ensure we have a portfolio of options to optimize our performance and leverage our assets to do so. We are clearly indicating that in Q2, Q3, we're leaning more into GoHealth Protect because of those dynamics we're observing. And once we can see more conclusive behavior in the fourth quarter — whether more SNP, more non-SNP, and which geographies within the country — we'll be better positioned to determine the extent of opportunity available in the fourth quarter.

Okay. And then, can you give us some balance sheet information, cash at the end of the quarter, and total debt?

Sure, let me give that to Brendan.

Yes, thank you. Cash at the end of the quarter was $22 million, and that is down from year-end.

And our next question will be coming from Dave Storms of Stonegate. Your line is open.

Good morning. Thanks for taking my questions. Just wanted to ask my first one around GoHealth Protect. You mentioned a lot of synergies and momentum expected into the second half of the year. What are some of the logistical hurdles you need to clear to facilitate that growth?

Sorry, can you repeat that question? I didn't catch it all.

Sorry, just around GoHealth Protect, some of the logistical hurdles you'll need to clear to see that growth through the second half of the year?

Yes. No, I mean, we're making sure that we have our agents all licensed. As I said, we have a significant portion of our floor who already have life insurance licenses. As we started this, we were always thoughtful. Our operating team has been impressive in taking a small test group, really seeking to understand what works, what doesn't work. Then, once they feel there's a scalable model, we ramp up our agents, ensure they are trained properly. For example, we were able to successfully ramp up agents during ETQ's onboarding within weeks of closing that transaction. So, once we proved that early in Q1, rolling into Q2, we began to scale back up those qualified agents while ensuring they are appointed appropriately and fed with the necessary leads to deliver. It's primarily about making sure everyone is licensed, appointed, and set up to operate within our tech to write that business. There's minimal fixed investment needed from us to achieve this growth. It's about marketing investment or leveraging existing marketing strategies to sell these products. Our goal is a thoughtful ramp rather than moving too quickly to avoid potential pitfalls.

Understood. Thank you. And then, more of a macro question. What kind of customer behavior do you see when the markets get volatile the way they are? Do you see more customers coming out to do plan fit checkups or more inbound calls?

If we go back to history last year, you can see we had significantly more opportunities that came through the door. More importantly, many of those opportunities were disproportionately from those who needed changes due to disruptions. There were a lot of plan exits last year. So, the question is how many plan exits will there be? Those are shoppers needing to make a change, whereas those losing benefits might shop due to cost implications. We generally see more people shopping when they hear about disruptions in the industry. We expect many shoppers this year, and our expectation is continued demand for shopping and comparison of options due to ongoing benefit repricing.

Thank you. I'm showing no further questions at this time. I would now like to turn the call back to Vijay Kotte, CEO, for closing remarks.

Well, thank you all for your time here. I know we've had a lot of really good questions. There's a lot that's exciting going on with GoHealth. There's a lot of things going on within the industry that we need to monitor. The health plans are continuing to reassess how they want to show up for Medicare Advantage. There's no doubt it's a valuable product serving many consumers. Those consumers need help figuring out what matches their needs. The health plans need assistance balancing their needs as well. The common denominator is players like GoHealth enabling that balance against the market dynamics. We're excited to see how this unfolds. We're working hard to monitor and react to market developments while ensuring our flexibility and capital structure, as we discussed earlier, to invest appropriately and seize available opportunities that are thoughtful and positive contributors to revenue, EBITDA, and cash position. All of those are vital balancing acts for us, and we want to ensure we are prepared for the market. Thank you for your time; we're excited about the opportunity ahead, and we look forward to speaking with you all again very soon.

Thank you for your participation in today's conference. This does conclude the program. You may now disconnect.